Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US-12006555-B2 · Jun 11, 2024 · US
This patent family groups 7 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 35064318 |
| Family type | — |
| Earliest priority | Mar 31, 2004 |
| First filing country | US |
| Member publications | 7 |
| Countries | US |
| Representative publication | US12006555B2 — Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
Best representative member for this family based on priority and filing country.
US12006555B2 — Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (published Jun 11, 2024)
Related publications in this family.
US-12006555-B2 · Jun 11, 2024 · US
US-2021017604-A1 · Jan 21, 2021 · US
US-10669589-B2 · Jun 2, 2020 · US
US-2018251860-A1 · Sep 6, 2018 · US
US-10000815-B2 · Jun 19, 2018 · US
US-2015176081-A1 · Jun 25, 2015 · US
US-9035036-B2 · May 19, 2015 · US